Quick Read
Hepato-Pancreato-Biliary (HPB) surgery treats some of the most anatomically connected—and physiologically unforgiving—problems in abdominal surgery. The liver, pancreas, gallbladder and bile ducts share vascular, ductal and digestive relationships, so a disease in one structure can affect several systems at once.
The distinct Medicine Web job is: liver/pancreas/biliary disease → anatomical and biological classification → resectability/operability assessment → multidisciplinary plan → open/laparoscopic/robotic operation where appropriate → resection and reconstruction → pathology → liver/pancreatic/biliary functional receipt → oncology/hepatology/endoscopy/transplant handoff → surveillance and long-term return.
Wait, What? Removing a Tumour Is Not the Same as Preserving Enough Organ
HPB surgery is constrained by what must remain. Liver resection must preserve enough functioning liver. Pancreatic resection can change digestion and glucose control. Bile-duct surgery may require complex reconstruction to restore drainage. The surgical question is therefore never only “Can this lesion be removed?” It is also “What function, flow and anatomy will remain afterwards?”
Core anti-collapse rules: lesion ≠ cancer; technically resectable ≠ automatically appropriate to resect; tumour removed ≠ oncology complete; liver volume ≠ liver function; pancreatic resection ≠ digestion unchanged.
The HPB Surgery Tube
Symptom/incidental finding → liver/pancreas/biliary localisation → imaging/endoscopy/pathology/laboratory evidence → benign/malignant/inflammatory classification → anatomy and physiological reserve → multidisciplinary treatment choice → resection/ablation/reconstruction where surgical → immediate postoperative organ state → pathology and margin receipt → nutrition/metabolic/biliary recovery → oncology/hepatology/endoscopy handoff → surveillance.
1. One Region Contains Several Different Clinical Objects
HPB surgery spans liver tumours, pancreatic tumours, gallbladder disease, bile-duct cancers, complex biliary injury, selected cystic disease, chronic pancreatitis and other benign or malignant disorders.
SGH’s Department of Hepato-Pancreato-Biliary and Transplant Surgery explicitly specialises in complex benign and malignant diseases of the liver, pancreas, gallbladder and bile ducts, confirming a genuine clinical ownership layer rather than a generic “abdominal surgery” bucket.
2. Imaging Has to Describe Surgical Geography
Cross-sectional imaging may need to define lesion size, segmental location, vascular involvement, biliary anatomy, pancreatic duct relationships, metastatic disease and the amount of viable organ that would remain after resection.
The Radiology & Imaging Web owns image acquisition and interpretation. HPB Surgery owns how those findings translate into operability, resection planes and reconstruction.
3. Liver Surgery Is a Balance Between Disease Clearance and Future Liver Reserve
Major and minor hepatectomy remove different volumes and anatomical territories. The operative plan depends not only on tumour location but also on liver quality, vascular inflow/outflow, biliary anatomy and expected future liver remnant.
SGH currently lists major hepatectomy, segmentectomy, staged hepatectomy and other advanced liver procedures within its HPB service. For eduKateAI, the key state is what is removed + what functional liver remains + what disease remains elsewhere.
4. Pancreatic Surgery Changes More Than Anatomy
The pancreas contributes digestive enzymes and endocrine hormones including insulin. Major pancreatic surgery can therefore alter both digestion and glucose regulation depending on how much tissue is removed and what function existed before surgery.
The Endocrine & Metabolic Medicine Web can receive postoperative glucose-control states, while the Clinical Nutrition Web receives malabsorption, intake and nutrition-support questions.
5. A Whipple Procedure Is a Reconstruction, Not Just a Resection
Pancreatoduodenectomy removes a connected set of structures around the pancreatic head and duodenum and then requires reconstruction of digestive continuity. SGH currently lists pancreatoduodenectomy among its major pancreatic operations.
For eduKateAI, the procedure should be represented as resection → pancreatic/biliary/gastrointestinal reconstruction → leak/function/nutrition receipt, not as one opaque procedure label.
6. Biliary Surgery Is a Flow-Reconstruction Problem
Bile must travel from liver to intestine. Obstruction, cancer, injury or complex gallstone disease can disrupt that route. Surgical treatment may involve bile-duct resection, exploration or reconstruction such as hepaticojejunostomy.
Anti-collapse rule: jaundice ≠ one diagnosis; biliary obstruction ≠ automatically surgical; drainage achieved ≠ underlying disease resolved.
7. Gallbladder Disease Ranges From Common to Oncologically Complex
Routine gallstone disease may be treated with cholecystectomy, while gallbladder cancer can require much more extensive oncological surgery. The same organ therefore contains radically different disease trajectories.
The information architecture must preserve benign gallstone disease separately from suspected or confirmed malignancy.
8. Endoscopy and Surgery Share the Biliary Tree but Own Different Moves
ERCP and EUS can diagnose and treat selected pancreaticobiliary problems without open surgery. The existing Advanced Interventional Endoscopy & Pancreatobiliary Therapy Web owns those endoscopic routes.
HPB Surgery owns the operative state when resection, major reconstruction or surgically controlled treatment is required. Shared anatomy does not imply duplicated ownership.
9. Oncology Owns the Cancer Trajectory
SGH describes routine multidisciplinary discussion with gastroenterology/hepatology, medical and radiation oncology, nuclear medicine, diagnostic radiology and interventional radiology. This matters because surgery may occur before, after or alongside systemic therapy, ablation or radiotherapy.
The Oncology Web owns overall cancer control; HPB Surgery owns the surgical segment.
10. Pathology Can Recompile the Postoperative Plan
Resected tissue can change staging, tumour classification, margin assessment and downstream treatment. A preoperative imaging impression is therefore not always the final disease state.
The Anatomical Pathology Web owns tissue interpretation; HPB Surgery receives the pathological receipt and passes it into the next oncological or surveillance decision.
11. Minimally Invasive Surgery Changes Access, Not the Fundamental Risk Equation
SGH reports extensive laparoscopic and robotic experience in complex liver, pancreatic and biliary procedures. These approaches can reduce access trauma in selected patients, but the underlying organ resection remains major surgery.
Useful anti-collapse rule: robotic or laparoscopic ≠ minor operation; smaller incision ≠ smaller biological consequence.
12. The Immediate Postoperative State Is Organ-Specific
After liver surgery, teams care about liver function, bleeding, bile leakage and perfusion. After pancreatic surgery, pancreatic fistula, delayed gastric emptying, infection and metabolic/nutritional changes may matter. After biliary reconstruction, drainage and leak states matter.
“Post-op HPB complication” is therefore too coarse for eduKateAI. Each complication requires a distinct route, evidence class and urgency.
13. Nutrition Is a Clinical Outcome, Not an Afterthought
Major HPB disease can cause weight loss before surgery, and pancreatic or gastrointestinal reconstruction may alter digestion afterwards. Nutrition status influences healing, strength and treatment tolerance.
The human outcome must include intake, weight trajectory, muscle/function, enzyme replacement where clinically prescribed, glucose state and the ability to resume ordinary eating.
14. Transplantation Is Adjacent but Not Absorbed
The SGH department includes transplant surgery, but the Medicine Web already has a dedicated Transplantation Medicine Web. HPB Surgery therefore owns liver surgery and operative HPB anatomy; transplantation owns donor-recipient matching, allocation, graft state, immunosuppression and long-term transplant trajectory.
15. The Human Receipt Is Organ Function Plus Life
A good surgical result is not only a clean margin or completed reconstruction. It is adequate liver/pancreatic/biliary function, freedom from major complications, nutrition and strength, disease control, ability to proceed to needed oncology, and return to meaningful daily life.
Evidence, Uncertainty and Limits
HPB surgery is strongly dependent on disease biology, anatomy, physiological reserve, liver quality, vascular relationships, treatment sequence and institutional expertise. High-volume-centre outcomes are informative but should not be converted into personal prognoses. “Resectable” and “operable” are related but different judgements, and both can change as evidence changes.
eduKateAI HPB Surgery Tube Card
- OBJECT: liver, pancreas, gallbladder or bile duct?
- DISEASE CLASS: benign, inflammatory, premalignant or malignant?
- ANATOMY: segment, duct, vessel and neighbouring-organ relationships?
- FUNCTION: baseline liver, pancreatic, biliary, nutritional and metabolic state?
- EVIDENCE: imaging, endoscopy, pathology and laboratory data?
- RESECTABILITY: can disease be removed anatomically?
- OPERABILITY: can the patient safely tolerate the intended treatment?
- ALTERNATIVES: surveillance, endoscopy, ablation, systemic therapy, radiotherapy or transplantation?
- PROCEDURE: liver resection, pancreatic resection, Whipple, cholecystectomy, bile-duct reconstruction or other?
- PATHOLOGY RECEIPT: final diagnosis, stage and margin state where relevant?
- ORGAN RECEIPT: liver function, pancreatic leak/function, biliary drainage, nutrition and glucose?
- RETURN: oncology, hepatology, nutrition, surveillance, revision or durable recovery?
Canonical External Sources
- Singapore General Hospital — Hepato-Pancreato-Biliary and Transplant Surgery
- SGH — HPB Clinical Services
- SGH — HPB Clinical Outcomes
Movement to the Next Nodes
- Non-surgical digestive/liver disease? → Gastrointestinal & Liver Medicine Web.
- ERCP/EUS or endoscopic pancreatobiliary therapy? → Advanced Interventional Endoscopy Web.
- Cancer trajectory? → Oncology Web.
- Transplant? → Transplantation Web.
- Nutrition? → Clinical Nutrition Web.
Educational boundary: This page explains HPB-surgery information architecture. It does not diagnose liver, pancreatic or biliary disease; interpret personal imaging or pathology; determine resectability or operability; recommend surgery; or replace qualified HPB, gastroenterology, oncology, radiology, nutrition or transplant care.
